$1,000,000 USD Raised

AP, LLC also known as Absorption Pharmaceuticals (AP), LLC has raised $1,000,000 USD from investors in the medical community. AP, LLC, a company started in 2008, is located in Newport Beach, California. AP, LLC is the developer of PROMESCENT, a FDA approved over-the-counter topical treatment for premature ejaculation.
The company is using this raised capital to develop two additional manufacturing plants. They are also going to use the funds to develop a stronger sales force.
PROMESCENT is viewed by the medical community as a well-supported solution for premature ejaculation. Many urologists in the US and globally are recommending this treatment to their patients.